Diabetes Drug Alert: Invokana

Invokana (canagliflozin) is an oral diabetes medication used to control blood sugar levels.

The FDA has recently strengthened the warning for Invokana due to reports of decreased bone mineral density and increased risk of bone fractures. The FDA reported that “fractures occur more frequently with canagliflozin than placebo,” adding that fractures can occur as early as 12 weeks after starting the drug.

In addition to bone density issues, Invokana has been under fire in recent months for other adverse side effects. Invokana – along with six other diabetes drugs – has been put on watch by the FDA for diabetic ketoacidosis. This occurs when levels of ketones (blood acid) are elevated. This complication often requires hospitalization or other emergency services and some patients report ongoing problems after the event.

Law Offices of Gary Green is taking cases resulting in diabetic coma, hospitalization or death within 30 days of taking Invokana. Contact Law Offices of Gary Green today to discuss your legal options without obligation. Call us toll-free at 1-888-4GARYGREEN or email ggreen@gGreen.com.

Print Friendly